References

1. Grubbé, E.H. Priority in the Therapeutic Use of X-rays. Radiology 1933, 21, 156–162.
2. Bernier, J.; Hall, E.J.; Giaccia, A. Radiation oncology: A century of achievements. Nat. Rev. Cancer 2004, 4, 737–747.
3. Delaney, G.; Jacob, S.; Featherstone, C.; Barton, M. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005, 104, 1129–1137.
4. De Ruysscher, D.; Niedermann, G.; Burnet, N.G.; Siva, S.; Lee, A.W.M.; Hegi-Johnson, F. Radiotherapy toxicity. Nat. Rev. Dis. Prim. 2019, 5, 1–20.
5. Wilson, R.R. Radiological use of fast protons. Radiology 1946, 47, 487–491.
6. Tobias, C.A.; Lawrence, J.H.; Born, J.L.; McCombs, R.K.; Roberts, J.E.; Anger, H.O.; Low-Beer, B.V.A.; Huggins, C.B. Pituitary Irradiation with High-Energy Proton Beams A Preliminary Report. Cancer Res. 1958, 18, 121–134.
7. Falkmer, S.; Fors, B.; Larsson, B.; Lindell, A.; Naeslund, J.; Stenson, S. Pilot Study on Proton Irradiation of Human Carcinoma. Acta Radiol. 1962, 58, 33–51.
8. Kjellberg, R.N.; Shintani, A.; Frantz, A.G.; Kliman, B. Proton-beam therapy in acromegaly. N. Engl. J. Med. 1968, 278, 689–695.
9. Suit, H.; Phil, D.; Goitein, M.; Munzenrider, J.; Verhey, L.; Blitzer, P.; Gragoudas, E.; Koehler, A.M.; Urie, M.; Gentry, R.; et al. Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8, 2199–2205.
10. Goitein, M.; Miller, T. Planning proton therapy of the eye. Med. Phys. 1983, 10, 275–283.
11. Thariat, J.; Hannoun-Levi, J.M.; Sun Myint, A.; Vuong, T.; Gérard, J.P. Past, present, and future of radiotherapy for the benefit of patients. Nat. Rev. Clin. Oncol. 2013, 10, 52–60.
12. Particle Therapy Co-Operative Group. Available online: https://www.ptcog.ch/ (accessed on 13 December 2020).
13. Yeung, D.K.; Palta, J.R. Precision and Uncertainties in Proton Therapy for Nonmoving Targets. In Proton Therapy Physics; Paganetti, H., Ed.; CRC Press: Boca Raton, FL, USA, 2012; pp. 413–433.
14. Engelsman, M.; Bert, C. Precision and Uncertainties in Proton Therapy for Moving Targets. In Proton Therapy Physics; Paganetti, H., Ed.; CRC Press: Boca Raton, FL, USA, 2012; pp. 435–459.
15. Paganetti, H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys. Med. Biol. 2012, 57, R99.
16. Unkelbach, J.; Paganetti, H. Robust Proton Treatment Planning: Physical and Biological Optimization. Semin. Radiat. Oncol. 2018, 28, 88–96.
17. De Ruysscher, D.; Sterpin, E.; Haustermans, K.; Depuydt, T. Tumour movement in proton therapy: Solutions and remaining questions: A review. Cancers 2015, 7, 1143–1153.
18. Parodi, K.; Polf, J.C. In vivo range verification in particle therapy. Med. Phys. 2018, 45, e1036–e1050.
19. Lomax, A.J. Myths and realities of range uncertainty. Br. J. Radiol. 2020, 93, 20190582.
20. Joiner, M. Linear energy transfer and relative biological effectiveness. In Basic Clinical Radiobiology; Joiner, M., van der Kogel, A., Eds.; Hodder Arnold: London, UK, 2009; pp. 68–77.
21. Paganetti, H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys. Med. Biol. 2014, 59, R419–R472.
22. Paganetti, H. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β. Acta Oncol. (Madr.) 2017, 56, 1379–1386.
23. Dasu, A.; Toma-Dasu, I. Impact of variable RBE on proton fractionation. Med. Phys. 2012, 40, 011705.
24. Paganetti, H.; Niemierko, A.; Ancukiewicz, M.; Gerweck, L.E.; Goitein, M.; Loeffler, J.S.; Suit, H.D. Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53, 407–421.
25. Nikjoo, H.; O’Neill, P.; Wilson, W.E.; Goodhead, D.T. Computational approach for determining the spectrum of DNA damage induced by ionizing radiation. Radiat. Res. 2001, 156, 577–583.
26. Courdi, A.; Brassart, N.; Herault, J.; Chauvel, P. The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. Br. J. Radiol. 1994, 67, 800–804.
27. Calugaru, V.; Nauraye, C.; Noël, G.; Giocanti, N.; Favaudon, V.; Mégnin-Chanet, F. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81, 1136–1143.
28. Cuaron, J.J.; Chang, C.; Lovelock, M.; Higginson, D.S.; Mah, D.; Cahlon, O.; Powell, S. Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks. Int. J. Radiat. Oncol. Biol. Phys. 2016, 95, 62–69.
29. Hojo, H.; Dohmae, T.; Hotta, K.; Kohno, R.; Motegi, A.; Yagishita, A.; Makinoshima, H.; Tsuchihara, K.; Akimoto, T. Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak. Radiat. Oncol. 2017, 12, 1–9.
30. Chaudhary, P.; Marshall, T.I.; Perozziello, F.M.; Manti, L.; Currell, F.J.; Hanton, F.; McMahon, S.J.; Kavanagh, J.N.; Cirrone, G.A.P.; Romano, F.; et al. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int. J. Radiat. Oncol. Biol. Phys. 2014, 90, 27–35.
31. Matsumoto, Y.; Matsuura, T.; Wada, M.; Egashira, Y.; Nishio, T.; Furusawa, Y. Enhanced radiobiological effects at the distal end of a clinical proton beam: In vitro study. J. Radiat. Res. 2014, 55, 816–822.
32. Bettega, D.; Calzolari, P.; Marchesini, R.; Noris Chiorda, G.L.; Piazzolla, A.; Tallone, L.; Cera, F.; Cherubini, R.; Dalla Vecchia, M.; Favaretto, S.; et al. Inactivation of C3H10T1/2 cells by low energy protons and deuterons. Int. J. Radiat. Biol. 1998, 73, 303–309.
33. Wéra, A.-C.; Heuskin, A.-C.; Riquier, H.; Michiels, C.; Lucas, S. Low-LET Proton Irradiation of A549 Non-small Cell Lung Adenocarcinoma Cells: Dose Response and RBE Determination. Radiat. Res. 2013, 179, 273–281.
34. Narang, H.; Kumar, A.; Bhat, N.; Pandey, B.N.; Ghosh, A. Effect of proton and gamma irradiation on human lung carcinoma cells: Gene expression, cell cycle, cell death, epithelial-mesenchymal transition and cancer-stem cell trait as biological end points. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2015, 780, 35–46.
35. Karger, C.P.; Peschke, P. RBE and related modeling in carbon-ion therapy. Phys. Med. Biol. 2018, 63, 01TR02.
36. Lühr, A.; von Neubeck, C.; Krause, M.; Troost, E.G.C. Relative biological effectiveness in proton beam therapy—Current knowledge and future challenges. Clin. Transl. Radiat. Oncol. 2018, 9, 35–41.
37. Paganetti, H. Proton relative biological effectiveness-uncertainties and opportunities. Int. J. Part. Ther. 2019, 5, 2–14.
38. Ilicic, K.; Combs, S.E.; Schmid, T.E. New insights in the relative radiobiological effectiveness of proton irradiation. Radiat. Oncol. 2018, 13, 6.
39. Willers, H.; Allen, A.; Grosshans, D.; McMahon, S.J.; von Neubeck, C.; Wiese, C.; Vikram, B. Toward A variable RBE for proton beam therapy. Radiother. Oncol. 2018, 128, 68–75.
40. Ödén, J.; DeLuca, P.M.; Orton, C.G. The use of a constant RBE=1.1 for proton radiotherapy is no longer appropriate. Med. Phys. 2018, 45, 502–505.
41. Jones, B.; McMahon, S.J.; Prise, K.M. The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness. Clin. Oncol. 2018, 30, 285–292.
42. Mavragani, I.V.; Nikitaki, Z.; Kalospyros, S.A.; Georgakilas, A.G. Ionizing radiation and complex DNA damage: From prediction to detection challenges and biological significance. Cancers 2019, 11, 1789.
43. Watanabe, R.; Rahmanian, S.; Nikjoo, H. Spectrum of Radiation-Induced Clustered Non-DSB Damage—A Monte Carlo Track Structure Modeling and Calculations. Radiat. Res. 2015, 183, 525–540.
44. Goodhead, D.T.; Nikjoo, H. Track structure analysis of ultrasoft X-rays compared to high- and low-LET radiations. Int. J. Radiat. Biol. 1989, 55, 513–529.
45. Chatzipapas, K.P.; Papadimitroulas, P.; Emfietzoglou, D.; Kalospyros, S.A.; Hada, M.; Georgakilas, A.G.; Kagadis, G.C. Ionizing radiation and complex DNA damage: Quantifying the radiobiological damage using Monte Carlo simulations. Cancers 2020, 12, 799.
46. Nikitaki, Z.; Nikolov, V.; Mavragani, I.V.; Plante, I.; Emfietzoglou, D.; Iliakis, G.; Georgakilas, A.G. Non-DSB clustered DNA lesions. Does theory colocalize with the experiment? Radiat. Phys. Chem. 2016, 128, 26–35.
47. Xu, X.; Nakano, T.; Tsuda, M.; Kanamoto, R.; Hirayama, R.; Uzawa, A.; Ide, H. Direct observation of damage clustering in irradiated DNA with atomic force microscopy. Nucleic Acids Res. 2020, 48, e18.
48. Rogakou, E.P.; Boon, C.; Redon, C.; Bonner, W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 1999, 146, 905–916.
49. Kinner, A.; Wu, W.; Staudt, C.; Iliakis, G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008, 36, 5678–5694.
50. Szymonowicz, K.; Krysztofiak, A.; van der Linden, J.; Kern, A.; Deycmar, S.; Oeck, S.; Squire, A.; Koska, B.; Hlouschek, J.; Vüllings, M.; et al. Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining. Cells 2020, 9, 889.
51. Desai, N.; Davis, E.; O’Neill, P.; Durante, M.; Cucinotta, F.A.; Wu, H. Immunofluorescence detection of clustered γ-H2AX foci induced by HZE-particle radiation. Radiat. Res. 2005, 164, 518–522.
52. Costes, S.V.; Boissière, A.; Ravani, S.; Romano, R.; Parvin, B.; Barcellos-Hoff, M.H. Imaging features that discriminate between foci induced by high- and low-LET radiation in human fibroblasts. Radiat. Res. 2006, 165, 505–515.
53. Leatherbarrow, E.L.; Harper, J.V.; Cucinotta, F.A.; O’Neill, P. Induction and quantification of γ-H2AX foci following low and high LET-irradiation. Int. J. Radiat. Biol. 2006, 82, 111–118.
54. Oeck, S.; Szymonowicz, K.; Wiel, G.; Krysztofiak, A.; Lambert, J.; Koska, B.; Iliakis, G.; Timmermann, B.; Jendrossek, V. Relating Linear Energy Transfer to the Formation and Resolution of DNA Repair Foci After Irradiation with Equal Doses of X-ray Photons, Plateau, or Bragg-Peak Protons. Int. J. Mol. Sci. 2018, 19, 3779.
55. Gerelchuluun, A.; Hong, Z.; Sun, L.; Suzuki, K.; Terunuma, T.; Yasuoka, K.; Sakae, T.; Moritake, T.; Tsuboi, K. Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines. Int. J. Radiat. Biol. 2011, 87, 57–70.
56. Bracalente, C.; Ibañez, I.L.; Molinari, B.; Palmieri, M.; Kreiner, A.; Valda, A.; Davidson, J.; Durán, H. Induction and Persistence of Large γH2AX Foci by High Linear Energy Transfer Radiation in DNA-Dependent protein kinase–Deficient Cells. Int. J. Radiat. Oncol. 2013, 87, 785–794.
57. Taleei, R. Modelling dsb repair kinetics for dna damage induced by proton and carbon ions. Radiat. Prot. Dosimetry 2019, 183, 75–78.
58. Pastwa, E.; Neumann, R.D.; Mezhevaya, K.; Winters, T.A. Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat. Res. 2003, 159, 251–261.
59. Carter, R.J.; Nickson, C.M.; Thompson, J.M.; Kacperek, A.; Hill, M.A.; Parsons, J.L. Complex DNA Damage Induced by High Linear Energy Transfer Alpha-Particles and Protons Triggers a Specific Cellular DNA Damage Response. Int. J. Radiat. Oncol. Biol. Phys. 2018, 100, 776–784.
60. Vitti, E.T.; Parsons, J.L. The radiobiological effects of proton beam therapy: Impact on DNA damage and repair. Cancers 2019, 11, 946.
61. Mitteer, R.A.; Wang, Y.; Shah, J.; Gordon, S.; Fager, M.; Butter, P.-P.; Kim, H.J.; Guardiola-Salmeron, C.; Carabe-Fernandez, A.; Fan, Y. Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species. Sci. Rep. 2015.
62. Grosse, N.; Fontana, A.O.; Hug, E.B.; Lomax, A.; Coray, A.; Augsburger, M.; Paganetti, H.; Sartori, A.A.; Pruschy, M. Deficiency in homologous recombination renders mammalian cells more sensitive to proton versus photon irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2014, 88, 175–181.
63. Georgakilas, A.G.; Stewart, R.D. Induction and Repair of Clustered DNA Lesions: What Do We Know So Far? Radiat. Res. 2013, 180, 100–109.
64. Eccles, L.J.; O’Neill, P.; Lomax, M.E. Delayed repair of radiation induced clustered DNA damage: Friend or foe? Mutat. Res. Fundam. Mol. Mech. Mutagen. 2011, 711, 134–141.
65. Minchom, A.; Aversa, C.; Lopez, J. Dancing with the DNA damage response: Next-generation anti-cancer therapeutic strategies. Ther. Adv. Med. Oncol. 2018, 10, 1–18.
66. Schwertman, P.; Bekker-Jensen, S.; Mailand, N. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat. Rev. Mol. Cell Biol. 2016, 17, 379–394.
67. Uckelmann, M.; Sixma, T.K. Histone ubiquitination in the DNA damage response. DNA Repair (Amst.) 2017, 56, 92–101.
68. Brinkmann, K.; Schell, M.; Hoppe, T.; Kashkar, H. Regulation of the DNA damage response by ubiquitin conjugation. Front. Genet. 2015, 6, 98.
69. Holt, S.M.; Georgakilas, A.G. Detection of complex DNA damage in γ-irradiated acute lymphoblastic leukemia pre-B NALM-6 cells. Radiat. Res. 2007, 168, 527–534.
70. Carter, R.J.; Nickson, C.M.; Thompson, J.M.; Kacperek, A.; Hill, M.A.; Parsons, J.L. Characterisation of Deubiquitylating Enzymes in the Cellular Response to High-LET Ionizing Radiation and Complex DNA Damage. Int. J. Radiat. Oncol. Biol. Phys. 2019, 104, 656–665.
71. Chang, H.H.Y.; Pannunzio, N.R.; Adachi, N.; Lieber, M.R. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 2017, 18, 495–506.
72. Scully, R.; Panday, A.; Elango, R.; Willis, N.A. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat. Rev. Mol. Cell Biol. 2019, 20, 698–714.
73. Mao, Z.; Bozzella, M.; Seluanov, A.; Gorbunova, V. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 2008, 7, 2902–2906.
74. Fontana, A.O.; Augsburger, M.A.; Grosse, N.; Guckenberger, M.; Lomax, A.J.; Sartori, A.A.; Pruschy, M.N. Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. Radiother. Oncol. 2015, 116, 374–380.
75. Liu, Q.; Ghosh, P.; Magpayo, N.; Testa, M.; Tang, S.; Gheorghiu, L.; Biggs, P.; Paganetti, H.; Efstathiou, J.A.; Lu, H.M.; et al. Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation. Int. J. Radiat. Oncol. Biol. Phys. 2015, 91, 1081–1089.
76. Liu, Q.; Underwood, T.S.A.; Kung, J.; Wang, M.; Lu, H.M.; Paganetti, H.; Held, K.D.; Hong, T.S.; Efstathiou, J.A.; Willers, H. Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation. Int. J. Radiat. Oncol. Biol. Phys. 2016, 95, 78–85.
77. Rostek, C.; Turner, E.L.; Robbins, M.; Rightnar, S.; Xiao, W.; Obenaus, A.; Harkness, T.A.A. Involvement of homologous recombination repair after proton-induced DNA damage. Mutagenesis 2008, 23, 119–129.
78. Bright, S.J.; Flint, D.B.; Chakraborty, S.; McFadden, C.H.; Yoon, D.S.; Bronk, L.; Titt, U.; Mohan, R.; Grosshans, D.R.; Sumazin, P.; et al. Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int. J. Radiat. Oncol. Biol. Phys. 2019, 105, 1119–1125.
79. Gerelchuluun, A.; Manabe, E.; Ishikawa, T.; Sun, L.; Itoh, K.; Sakae, T.; Suzuki, K.; Hirayama, R.; Asaithamby, A.; Chen, D.J.; et al. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions. Radiat. Res. 2015, 183, 345–356.
80. Keta, O.D.; Todorović, D.V.; Bulat, T.M.; Cirrone, P.G.; Romano, F.; Cuttone, G.; Petrović, I.M.; Ristić Fira, A.M. Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions. Exp. Biol. Med. 2017, 242, 1015–1024.
81. Di Pietro, C.; Piro, S.; Tabbì, G.; Ragusa, M.; Di Pietro, V.; Zimmitti, V.; Cuda, F.; Anello, M.; Consoli, U.; Salinaro, E.T.; et al. Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy. Apoptosis 2006, 11, 57–66.
82. Moertel, H.; Georgi, J.C.; Distel, L.; Eyrich, W.; Fritsch, M.; Grabenbauer, G.; Sauer, R. Effects of low energy protons on clonogenic survival, DSB repair and cell cycle in human glioblastoma cells and B14 fibroblasts. Radiother. Oncol. 2004, 73, S115–S118.
83. Antoccia, A.; Sgura, A.; Berardinelli, F.; Cavinato, M.; Cherubini, R.; Gerardi, S.; Tanzarella, C. Cell cycle perturbations and genotoxic effects in human primary fibroblasts induced by low-energy protons and X/γ-rays. J. Radiat. Res. 2009, 50, 457–468.
84. Hartfiel, S.; Häfner, M.; Perez, R.L.; Rühle, A.; Trinh, T.; Debus, J.; Huber, P.E.; Nicolay, N.H. Differential response of esophageal cancer cells to particle irradiation. Radiat. Oncol. 2019, 14, 119.
85. Finnberg, N.; Wambi, C.; Ware, J.H.; Kennedy, A.R.; El-Deiry, W.S. Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol. Ther. 2008, 7, 2023–2033.
86. Wang, L.; Yang, L.; Han, S.; Zhu, J.; Li, Y.; Wang, Z.; Fan, Y.H.; Lin, E.; Zhang, R.; Sahoo, N.; et al. Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy. Head Neck 2019, 42, 289–301.